Reduced ovarian complement, premature ovarian failure, and down syndrome [5]

American Journal of Medical Genetics

Volumn 99, Issue 2, 2001, Pages 168-169

  Salamanca Gómez, Fabio ^a,b   Buentello, Leonor ^a   Salamanca Buentello, Fabio ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; FOLLITROPIN; RIBOSOME DNA; RIBOSOME RNA;

AUTOSOME; CHROMOSOME 21; CHROMOSOME NOR; CHROMOSOME TRANSLOCATION; DOWN SYNDROME; FEMALE; GENE LOSS; GENETIC RISK; HORMONE BLOOD LEVEL; HUMAN; LETTER; MATERNAL AGE; NONDISJUNCTION; OVARY INSUFFICIENCY; PRIORITY JOURNAL; PROGENY;

AGING; DOWN SYNDROME; FEMALE; HUMANS; OVARIAN FAILURE, PREMATURE; OVARY;

EID: 0035282203     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-8628(2000)9999:999<00::AID-AJMG1131>3.0.CO;2-M     Document Type: Letter

References (6)

1. Women with a reduced ovarian complement may have an increased risk for a child with Down Syndrome
2. Telomeres shorten during aging of human fibroblasts
3. Imprinting effect in premature ovarian failure confined to paternally inherited Fragile X premutations
4. Loss of genes coding for rRNA in ageing brain cells
5. Ribosomal RNA, maternal age, and Down Syndrome
6. Mechanisms of disease: Receptor autoimmunity in endocrine disorders